BioSpace News Archive

HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, announced that the company will participate in the virtual 11th Annual SVB Leerink Global Healthcare Conference, February 14 - 18, 2022.

Atea Pharmaceuticals, Inc. announced that Jean-Pierre Sommadossi, Ph.D., Chief Executive Officer and Founder of Atea Pharmaceuticals together with other members of the Atea management team, will participate in a fireside chat and provide a business update at the 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17, 2022 at 2:20 p.m. ET.

Pardes Biosciences, Inc. announced that a virtual investor event will be hosted by the company’s management team following the presentation of clinical data from the ongoing PBI-0451 Phase 1 trial at the 29th Conference On Retroviruses And Opportunistic Infections 2022.

Aptinyx Inc. will host a virtual portfolio review event today beginning at 10:00 a.m. ET. Presented in a live webcast format, the company will discuss its approach to the development of novel NMDA receptor modulators.

Nephros, Inc. today announced that it will file its fourth quarter financial results on Wednesday, February 23, 2022 after market close and will host a conference call that same day at 4:30 PM ET.

BIONIK Laboratories Corp. today reported financial results for the third quarter and first nine months of fiscal year 2022, ended December 31, 2021.

CRISPR Therapeutics announced that members of its senior management team are scheduled to participate in the 11th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 16, 2022, at 1:40 p.m. ET.

Assembly Biosciences, Inc. announced that John McHutchison, AO, MD, chief executive officer and president, will participate in a virtual fireside chat during the SVB Leerink 11th Annual Global Healthcare Conference on Thursday, February 17, 2022 at 3:40 p.m. ET.

Athenex, Inc. announced that Johnson Lau, CEO and Board Chairman, and Daniel Lang, President, Athenex Cell Therapy, will present at the 11th Annual SVB Leerink Global healthcare Conference on Thursday, February 17, 2022, at 3:00 P.M. ET.

Immunovant, Inc., a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, announced that Pete Salzmann, M.D., Chief Executive Officer, will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference, taking place February 14 - 18, 2022.